Search

Your search keyword '"Xu, Linzhi"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Xu, Linzhi" Remove constraint Author: "Xu, Linzhi"
133 results on '"Xu, Linzhi"'

Search Results

8. MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

9. The adipokine profile of metabolically benign obese and at‐risk normal weight postmenopausal women: The Women's Health Initiative Observational Study

11. Interactive Spaced Online Education in Pediatric Trauma

12. OAB-056: Early, deep, and durable responses, and low rates of cytokine release syndrome with REGN5458, a BCMAxCD3 bispecific antibody, in a Phase 1/2 study in patients with relapsed/refractory multiple myeloma

17. Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

18. Perception of weight status and its impact on gestational weight gain in an urban population

21. REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

22. A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 and LAG-3, in patients with unresectable or metastatic neoplasms.

24. Role of contractile reserve as a predictor of mortality in low‐flow, low‐gradient severe aortic stenosis following transcatheter aortic valve replacement

25. Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement

26. DOES LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN DIFFERENTIATE LOW-FLOW, LOW-GRADIENT SEVERE AORTIC STENOSIS PATIENTS IN ADDITION TO CONVENTIONAL CONTRACTILE RESERVE ASSESSMENT?

28. UTILITY OF AN ADDITIVE FRAILTY TESTS SCORE FOR MORTALITY RISK ASSESSMENT FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT

29. THE IMPACT OF P2Y12 INHIBITORS SWITCH IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH DRUG-ELUTING STENTS PRIOR TO DISCHARGE

31. IN-STENT RESTENOSIS OF DRUG-ELUTING STENTS COMPARED TO A MATCHED GROUP OF PATIENTS WITH DE NOVO CORONARY ARTERY STENOSIS

33. TCT-91 Antithrombotic therapy post transcatheter aortic valve replacement in patients with no indication for anticoagulation

34. TCT-146 The impact of clinical frailty on one-year mortality post transcatheter aortic valve replacement

35. TCT-786 Antithrombotic Management for Atrial Fibrillation Patient Undergoing Transcatheter Aortic Valve Replacement

37. TCT-147 Short and long term transcatheter aortic valve replacement outcome using clinical frailty status

38. Reproductive and menstrual factors and colorectal cancer incidence in the Women’s Health Initiative Observational Study

40. Poster: MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

45. Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study.

46. The adipokine profile of metabolically benign obese and at‐risk normal weight postmenopausal women: The Women's Health Initiative Observational Study

Catalog

Books, media, physical & digital resources